Search - tctmd.com

Displaying 41 - 60 of 92

Sort: Relevancy | Date

News Daily News

‘Watchful Waiting’ Spells More Death in Asymptomatic AS, Meta-analysis Confirms

L.A. McKeown

July 17, 2020

News Conference News EuroPCR 2020

Novel Ultrasound Therapy Shows Promise for Patients Unfit for TAVR, SAVR

L.A. McKeown

July 01, 2020

News Conference News EuroPCR 2020

‘Suboptimal’ Outcomes in Real-world Mitral Valve-in-Valve, Valve-in-Ring: VIVID Registry

Yael L. Maxwell

July 01, 2020

News Conference News TVT 2020

Stroke in TAVR: Full Impact of Embolic Devices, Anticoagulants, Technique Remain Unclear

Todd Neale

June 25, 2020

News Conference News TVT 2020

Device Explants After TAVR Rare but Risky

Michael O'Riordan

June 24, 2020

News Conference News TVT 2020

Reduced Leaflet Motion After TAVR: No Link to Impaired Hemodynamics, Events

Michael O'Riordan

June 23, 2020

News Conference News TVT 2020

Sapien 3 in Intermediate Risk: Death or Stroke Similar to SAVR at 5 Years

Michael O'Riordan

June 22, 2020

Presentation TVT 2020

Transcatheter Aortic Valve Replacement using an Evolut PRO Bioprosthesis in Low Risk Patients with Aortic Stenosis

Presenter: Bruce Rutkin

June 20, 2020

News Conference News TVT 2020

Skipping Predilatation in Low-risk TAVR Patients Does Not Mar Outcomes

L.A. McKeown

June 19, 2020

News Daily News

Most US Patients Have TAVR Options Nearby, but Proximity Isn’t Everything

Todd Neale

June 12, 2020

News Daily News

Cardiogenic Shock Spells Poor Outcomes Despite Successful TAVR

Todd Neale

June 02, 2020

News Daily News

Good Results With Next-Gen, Self-Expanding TAVR in Bicuspid Valves

Michael O'Riordan

May 27, 2020

News Conference News SCAI 2020

Late and Early Results in Tune for Melody and Harmony Transcatheter PVs

Caitlin E. Cox

May 25, 2020

News Conference News HRS 2020

Permanent Conduction-System Pacing After TAVR? Don’t ‘Diss the His’

Michael O'Riordan

May 21, 2020

News Daily News

LV Mass Regression After TAVR Linked to Better Long-term Outcomes

Michael O'Riordan

May 13, 2020

News Features

Hospitals Plan Cautious Restart to Elective Procedures as COVID-19 Wanes

Michael O'Riordan

May 12, 2020

News Daily News

Structural Heart Interventions in the Midst of COVID-19: Today’s Advice, Tomorrow’s Unknowns

Shelley Wood

April 13, 2020

News Features

‘Salvage What We Can’: Cardiology Clinical Trials in Turmoil Amid COVID-19

Michael O'Riordan

April 07, 2020

News Conference News ACC 2020

Early Data Support TAVR in Bicuspid Valves, but Questions Remain

Michael O'Riordan

March 29, 2020

News Conference News ACC 2020

PARTNER 3: TAVR Now Noninferior to Surgery at 2 Years in Low-Risk Patients

Yael L. Maxwell

March 29, 2020

Advertisement

‘Watchful Waiting’ Spells More Death in Asymptomatic AS, Meta-analysis Confirms

Novel Ultrasound Therapy Shows Promise for Patients Unfit for TAVR, SAVR

‘Suboptimal’ Outcomes in Real-world Mitral Valve-in-Valve, Valve-in-Ring: VIVID Registry

Stroke in TAVR: Full Impact of Embolic Devices, Anticoagulants, Technique Remain Unclear

Device Explants After TAVR Rare but Risky

Reduced Leaflet Motion After TAVR: No Link to Impaired Hemodynamics, Events

Sapien 3 in Intermediate Risk: Death or Stroke Similar to SAVR at 5 Years

Transcatheter Aortic Valve Replacement using an Evolut PRO Bioprosthesis in Low Risk Patients with Aortic Stenosis

Skipping Predilatation in Low-risk TAVR Patients Does Not Mar Outcomes

Most US Patients Have TAVR Options Nearby, but Proximity Isn’t Everything

Cardiogenic Shock Spells Poor Outcomes Despite Successful TAVR

Good Results With Next-Gen, Self-Expanding TAVR in Bicuspid Valves

Late and Early Results in Tune for Melody and Harmony Transcatheter PVs

Permanent Conduction-System Pacing After TAVR? Don’t ‘Diss the His’

LV Mass Regression After TAVR Linked to Better Long-term Outcomes

Hospitals Plan Cautious Restart to Elective Procedures as COVID-19 Wanes

Structural Heart Interventions in the Midst of COVID-19: Today’s Advice, Tomorrow’s Unknowns

‘Salvage What We Can’: Cardiology Clinical Trials in Turmoil Amid COVID-19

Early Data Support TAVR in Bicuspid Valves, but Questions Remain

PARTNER 3: TAVR Now Noninferior to Surgery at 2 Years in Low-Risk Patients

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content